Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor Xa Inhibitor”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Post-approval studies (Phase 4)Looking for participantsNCT07521332
What this trial is testing

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

Who this might be right for
CirrhosisEsophageal and Gastric VaricesAscites+3 more
Asian Institute Of Medical Sciences 220
Testing effectiveness (Phase 2)Study completedNCT00839163
What this trial is testing

Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)

Who this might be right for
Venous ThrombosisDeep Vein Thrombosis
Bayer 613
Testing effectiveness (Phase 2)Study completedNCT00839826
What this trial is testing

ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial

Who this might be right for
ThromboembolismPrevention
Bayer 641
Post-approval studies (Phase 4)Looking for participantsNCT04258488
What this trial is testing

Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement

Who this might be right for
AORTIC VALVE DISEASESThromboembolism
Joon Bum Kim 1,300
Large-scale testing (Phase 3)Looking for participantsNCT06878066
What this trial is testing

Thrombolysis in Factor Xa-inhibitors Trial

Who this might be right for
StrokeStroke (in Patients With Atrial Fibrillation)Ischemic Stroke+6 more
Guri Hagberg 300
Testing effectiveness (Phase 2)Study completedNCT01203098
What this trial is testing

A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

Who this might be right for
Venous ThromboembolismThromboembolismThrombosis+3 more
Daiichi Sankyo Co., Ltd. 264
Large-scale testing (Phase 3)Study completedNCT01181167
What this trial is testing

DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

Who this might be right for
PreventionVenous Thromboembolism
Daiichi Sankyo Co., Ltd. 610
Testing effectiveness (Phase 2)Study completedNCT00973323
What this trial is testing

BAY59-7939 Japanese in Atrial Fibrillation (2nd)

Who this might be right for
Atrial Fibrillation
Bayer 100
Large-scale testing (Phase 3)UnknownNCT04171726
What this trial is testing

Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation

Who this might be right for
Aortic Valve Stenosis
Erasmus Medical Center 100
Not applicableWithdrawnNCT01523418
What this trial is testing

Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)

Who this might be right for
Prophylaxis, Thromboembolism, VenousTotal Knee ReplacementTotal Hip Replacement
Bayer
Large-scale testing (Phase 3)Study completedNCT00439777
What this trial is testing

Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study

Who this might be right for
Pulmonary Embolism
Bayer 4,833
Post-approval studies (Phase 4)Ended earlyNCT02945280
What this trial is testing

Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis

Who this might be right for
Deep Venous ThrombosisUpper Extremity Deep Venous ThrombosisThrombus+2 more
Intermountain Health Care, Inc. 52
Early research (Phase 1)Study completedNCT03218241
What this trial is testing

Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote

Who this might be right for
Healthy
Portola Pharmaceuticals 32
Early research (Phase 1)Study completedNCT07312851
What this trial is testing

Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 191
Not applicableStudy completedNCT02464488
What this trial is testing

New Oral Direct Anticoagulants in Patients 80 Years Old and Over : a Population Pharmacokinetics Study

Who this might be right for
Atrial Fibrillation
Hôpital Charles Foix 232
Large-scale testing (Phase 3)Study completedNCT02329327
What this trial is testing

A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study)

Who this might be right for
Bleeding
Alexion Pharmaceuticals, Inc. 479
Post-approval studies (Phase 4)Looking for participantsNCT06402851
What this trial is testing

Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)

Who this might be right for
Atrium; FibrillationChronic Kidney Diseases
Hospital Sirio-Libanes 1,500
Not applicableUnknownNCT02635230
What this trial is testing

What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.

Who this might be right for
Atrial FibrillationsHeart Valve ProsthesesAcute Coronary Syndromes+4 more
R&D Cardiologie 2,200
Not applicableStudy completedNCT06147830
What this trial is testing

Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment

Who this might be right for
Major Bleeding
AstraZeneca 2,202
Not applicableLooking for participantsNCT05454787
What this trial is testing

Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)

Who this might be right for
Life Threatening BleedingFactor Xa Inhibitor
AstraZeneca 300
Next Page